{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:34:24Z","timestamp":1770071664542,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T00:00:00Z","timestamp":1450396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00330-015-4156-7","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T22:10:54Z","timestamp":1450476654000},"page":"3272-3279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Prediction of disease progression following concurrent chemoradiotherapy for uterine cervical cancer: value of post-treatment diffusion-weighted imaging"],"prefix":"10.1007","volume":"26","author":[{"given":"Jung Jae","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0482-1140","authenticated-orcid":false,"given":"Chan Kyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Kwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,18]]},"reference":[{"key":"4156_CR1","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","volume":"340","author":"PG Rose","year":"1999","unstructured":"Rose PG, Bundy BN, Watkins EB et al (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144\u20131153","journal-title":"N Engl J Med"},{"key":"4156_CR2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1634\/theoncologist.2002-0342","volume":"7","author":"M Friedlander","year":"2002","unstructured":"Friedlander M, Grogan M (2002) Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist 7:342\u2013347","journal-title":"Oncologist"},{"key":"4156_CR3","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/j.ygyno.2007.07.015","volume":"107","author":"P Morice","year":"2007","unstructured":"Morice P, Uzan C, Zafrani Y, Delpech Y, Gouy S, Haie-Meder C (2007) The role of surgery after chemoradiation therapy and brachytherapy for stage IB2\/II cervical cancer. Gynecol Oncol 107:S122\u2013S124","journal-title":"Gynecol Oncol"},{"key":"4156_CR4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1634\/theoncologist.2009-0295","volume":"15","author":"C Touboul","year":"2010","unstructured":"Touboul C, Uzan C, Mauguen A et al (2010) Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer. Oncologist 15:405\u2013415","journal-title":"Oncologist"},{"key":"4156_CR5","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1001\/jama.298.19.2289","volume":"298","author":"JK Schwarz","year":"2007","unstructured":"Schwarz JK, Siegel BA, Dehdashti F, Grigsby PW (2007) Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA 298:2289\u20132295","journal-title":"JAMA"},{"key":"4156_CR6","volume":"12","author":"S Tangjitgamol","year":"2014","unstructured":"Tangjitgamol S, Katanyoo K, Laopaiboon M, Lumbiganon P, Manusirivithaya S, Supawattanabodee B (2014) Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer. Cochrane Database Syst Rev 12, CD010401","journal-title":"Cochrane Database Syst Rev"},{"key":"4156_CR7","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s00330-010-1998-x","volume":"21","author":"C Balleyguier","year":"2011","unstructured":"Balleyguier C, Sala E, Da Cunha T et al (2011) Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur Radiol 21:1102\u20131110","journal-title":"Eur Radiol"},{"key":"4156_CR8","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/cncr.23817","volume":"113","author":"E Vincens","year":"2008","unstructured":"Vincens E, Balleyguier C, Rey A et al (2008) Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2\/II cervical carcinoma with chemoradiation therapy: correlation of radiologic findings with surgicopathologic results. Cancer 113:2158\u20132165","journal-title":"Cancer"},{"key":"4156_CR9","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.2214\/AJR.06.1403","volume":"188","author":"DM Koh","year":"2007","unstructured":"Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188:1622\u20131635","journal-title":"AJR Am J Roentgenol"},{"key":"4156_CR10","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1200\/JCO.2007.11.9610","volume":"25","author":"DA Hamstra","year":"2007","unstructured":"Hamstra DA, Rehemtulla A, Ross BD (2007) Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol 25:4104\u20134109","journal-title":"J Clin Oncol"},{"key":"4156_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00330-004-2529-4","volume":"15","author":"S Naganawa","year":"2005","unstructured":"Naganawa S, Sato C, Kumada H, Ishigaki T, Miura S, Takizawa O (2005) Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 15:71\u201378","journal-title":"Eur Radiol"},{"key":"4156_CR12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ygyno.2008.07.048","volume":"111","author":"VN Harry","year":"2008","unstructured":"Harry VN, Semple SI, Gilbert FJ, Parkin DE (2008) Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 111:213\u2013220","journal-title":"Gynecol Oncol"},{"key":"4156_CR13","doi-asserted-by":"crossref","unstructured":"Schreuder SM, Lensing R, Stoker J, Bipat S (2015) Monitoring treatment response in patients undergoing chemoradiotherapy for locally advanced uterine cervical cancer by additional diffusion-weighted imaging: A systematic review. J Magn Reson Imaging 42:572\u201394","DOI":"10.1002\/jmri.24784"},{"key":"4156_CR14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1148\/radiol.11102135","volume":"260","author":"MJ Park","year":"2011","unstructured":"Park MJ, Kim SH, Lee SJ, Jang KM, Rhim H (2011) Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. Radiology 260:771\u2013780","journal-title":"Radiology"},{"key":"4156_CR15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijgo.2009.02.009","volume":"105","author":"S Pecorelli","year":"2009","unstructured":"Pecorelli S, Zigliani L, Odicino F (2009) Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet 105:107\u2013108","journal-title":"Int J Gynaecol Obstet"},{"key":"4156_CR16","doi-asserted-by":"crossref","first-page":"v37","DOI":"10.1093\/annonc\/mdq162","volume":"21","author":"C Haie-Meder","year":"2010","unstructured":"Haie-Meder C, Morice P, Castiglione M (2010) Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 21:v37\u2013v40","journal-title":"Ann Oncol"},{"key":"4156_CR17","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1002\/cncr.25991","volume":"117","author":"S Siva","year":"2011","unstructured":"Siva S, Herschtal A, Thomas JM et al (2011) Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer. Cancer 117:3981\u20133988","journal-title":"Cancer"},{"key":"4156_CR18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1593\/neo.81328","volume":"11","author":"AR Padhani","year":"2009","unstructured":"Padhani AR, Liu G, Koh DM et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102\u2013125","journal-title":"Neoplasia"},{"key":"4156_CR19","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2214\/ajr.180.6.1801621","volume":"180","author":"H Kaur","year":"2003","unstructured":"Kaur H, Silverman PM, Iyer RB, Verschraegen CF, Eifel PJ, Charnsangavej C (2003) Diagnosis, staging, and surveillance of cervical carcinoma. AJR Am J Roentgenol 180:1621\u20131631","journal-title":"AJR Am J Roentgenol"},{"key":"4156_CR20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1102\/1470-7330.2007.0011","volume":"7","author":"KR Zand","year":"2007","unstructured":"Zand KR, Reinhold C, Abe H, Maheshwari S, Mohamed A, Upegui D (2007) Magnetic resonance imaging of the cervix. Cancer Imaging 7:69\u201376","journal-title":"Cancer Imaging"},{"key":"4156_CR21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1148\/radiology.204.1.9205223","volume":"204","author":"K Kinkel","year":"1997","unstructured":"Kinkel K, Ariche M, Tardivon AA et al (1997) Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging. Radiology 204:55\u201363","journal-title":"Radiology"},{"key":"4156_CR22","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1148\/radiol.14140920","volume":"274","author":"JJ Park","year":"2015","unstructured":"Park JJ, Kim CK, Park SY, Park BK (2015) Parametrial invasion in cervical cancer: fused T2-weighted imaging and high-b-value diffusion-weighted imaging with background body signal suppression at 3 T. Radiology 274:734\u2013741","journal-title":"Radiology"},{"key":"4156_CR23","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.2004.07.197","volume":"22","author":"PJ Eifel","year":"2004","unstructured":"Eifel PJ, Winter K, Morris M et al (2004) Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 22:872\u2013880","journal-title":"J Clin Oncol"},{"key":"4156_CR24","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1200\/JCO.2001.19.17.3745","volume":"19","author":"PW Grigsby","year":"2001","unstructured":"Grigsby PW, Siegel BA, Dehdashti F (2001) Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 19:3745\u20133749","journal-title":"J Clin Oncol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-015-4156-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-015-4156-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-015-4156-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T23:57:48Z","timestamp":1599955068000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-015-4156-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,18]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["4156"],"URL":"https:\/\/doi.org\/10.1007\/s00330-015-4156-7","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,18]]}}}